ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281817; 2) Community: the network communities that were significantly associated with the response to NSC 281817; 3) Molecule: the relationships between components within communities and NSC 281817; 4) MDR: the compounds that were significantly associated with the NSC 281817.

NSC Compound Enrichment Correlation
NSC 722508 2-(4-ethylpiperazinyl)3-p-methoxybenzoyl quinoxaline 0.0141370771633662 0.045522177
NSC 730946 4-(2-(4-methoxyphenyl)ethynyl)-3-(3,4,5-trimethoxyphenyl)fur an-2(5H)-one 0.0141370771633662 0.11974344
NSC 736394 6-(3-Aminopropyl)-9-fluoro-5,6-dihydro-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline Hydrochloride 0.0141370771633662 0.38775278
NSC 740644 6-(3-Bromopropyl)-9-ethoxy-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0141370771633662 0.41870025
NSC 100880 Camptothecin 0.0147237897640499 0.50573386
NSC 105014 Cladribine 0.0147237897640499 0.21186148
NSC 132313 Dianhydrogalactitol 0.0147237897640499 0.6603934
NSC 267713 Digitoxigenin glycoside 0.0147237897640499 0.38566386
NSC 303812 Aphidicoline glycinate 0.0147237897640499 0.62510664
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0147237897640499 0.34344166
Total:66  Current:19    [First] [Prev] [Next] [Last]